1. Merlini G, Bellotti V: Molecular mechanisms of amyloidosis. N
Engl J Med 2003; 349: 583-596
2. Hur E, Taskin H, Bozkurt D, Sarsik B, Sen S, Ertilav M, Sipahi S,
Basci A, Akcicek F, Duman S: Adult native renal biopsy experience
of Ege University for 12 consecutive years. BANTAO Journal
2010; 8(1): 22-29
3. Danovitch GM, Le Roith D, Sikuler SE, Straus R: Amyloid goitre
in familial Mediterranean fever. Clin Endocrinol (Oxf) 1979; 11:
595-601
4. Levy M, YaVe C: Testicular function in patients with familial
Mediterranean fever on long-term colchicine treatment. Fertil Steril
1978; 29: 667-6685. Ozdemir D, Dagdelen S, Erbas T: Endocrine involvement in
systemic amyloidosis. Endocr Pract 2010; 16(6): 1056-1063
6. Erdkamp FL, Gans ROB, Hoorntje SJ: Endocrine organ failure due
to systemic AA-amyloidosis. Neth J Med 1991; 38: 24-28
7. Muro K, Kobayashi M, Shimizu Y, Kikuchi S, Yamaguchi N,
Inadome Y, Watanabe T, Koyama A: A case of systemic AA
amyloidosis complicating Crohn’s disease. Nippon Jinzo Gakkai
Shi 1998; 40: 284-289
8. DiSalvo TG, King ME, Smith RN: Case Records of the Massachusetts
General Hospital. Weekly clinicopathological exercises. Case
3-2000. A 66-year-old woman with diabetes, coronary disease,
orthostatic hypotension and the nephrotic syndrome. N Engl J Med
2000; 342: 264-273
9. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin
CA, Gillmore JD, Hawkins PN: Natural history and outcome in
systemic AA amyloidosis. N Engl J Med 2007; 356: 2361-2371
10. Emeksiz H, Bakkaloglu S, Camurdan O, Boyraz M, Soylemezoglu
O, Hasanoglu E, Buyan N: Acute adrenal crisis mimicking familial
Mediterranean fever attack in a renal transplant FMF patient with
amyloid goiter. Rheumatol Int 2010; 30(12): 1647-1649
11. Keven K, Oztas E, Aksoy H, Duman N, Erbay B, Ertürk S:
Polyglandular endocrine failure in a patient with amyloidosis
secondary to familial Mediterranean fever. Am J Kidney Dis 2001;
38(6): E39
12. Arik N, Tasdemir I, Karaaslan Y, Yasavul U, Turgan C, Caglar
S: Subclinical adrenocortical insuffi ciency in renal amyloidosis.
Nephron 1990; 56: 246-248
13. Gündüz Z, Keleştimur F, Durak AC, Utaş C, Büyükberber M,
Düşünsel R, Kurtoğlu S, Poyrazoglu MH: The hormonal and
radiological evaluation of adrenal glands, and the determination
of the usefulness of low dose ACTH test in patients with renal
amyloidosis. Ren Fail 2001; 23: 239-249
14. Olofsson BO, Grankvist K, Boman K, Forsberg K, Lafvas I, Lithner
F: Assessment of thyroid and adrenal function in patients with
familial amyloidotic polyneuropathy. J Intern Med 1989; 225: 337-
341
15. Pişkinpaşa S, Dede F, Akoğlu H, Doğru F, Yenigün EC, Öztürk R,
Özkayar R, Turgut D, Koç E, Odabaş AR: Böbrek biyopsilerinin
klinikopatolojik değerlendirmesi: Tek merkez deneyimi. Turk Neph
Dial Transpl 2012; 21(2): 167-172
16. Piskinpasa S, Akoglu H, Koc E, Dogru F, Coskun EY, Turgut D,
Ozkayar N, Ozturk R, Odabas AR, Dede F: Revisiting secondary
amyloidosis for an inadequately investigated feature: Dyslipidemia.
Rheumatol Int 2013; 33(4): 993-999
17. Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu
S, Ataman R, Akpolat T, Ok E, Sen S, Düsünsel R, Evrenkaya
R, Akoglu E: A retrospective analysis for aetiology and clinical
fi ndings of 287 secondary amyloidosis cases in Turkey. Nephrol
Dial Transplant 2002; 17(11): 2003-2005
Thank you for copying data from http://www.arastirmax.com
